MaaT Pharma SA (EPA: MAAT)
France
· Delayed Price · Currency is EUR 7.42
+0.14 (1.92%)
Sep 25, 2024, 5:35 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €103.83 million as of September 26, 2024. Its market cap has increased by 44.46% in one year.
Market Cap
103.83M
Enterprise Value
89.85M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.42
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 103.83M, a decrease of -21.77%. That is a compound annual growth rate of -8.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2024 | 103.83M | 28.20% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 129.28B |
| EssilorLuxottica Société anonyme | 92.66B |
| Sartorius Stedim Biotech S.A. | 16.78B |
| bioMérieux S.A. | 12.85B |
| Eurofins Scientific SE | 10.10B |
| Ipsen S.A. | 9.08B |
| Virbac SA | 3.30B |
| Ramsay Générale de Santé SA | 1.61B |